Gain Therapeutics Inc reports decreased full year loss, with improved earnings per share

From Nasdaq: 2025-03-27 07:38:00

Gain Therapeutics Inc (GANX) reported a loss of $20.41 million for the full year. Earnings came in at -$0.89 per share, an improvement from last year’s -$1.71 per share when the loss was $22.27 million. The company’s GAAP earnings show a decrease in losses compared to the previous year.

In summary, Gain Therapeutics Inc’s earnings for the full year were -$20.41 million, with earnings per share at -$0.89. This marks an improvement from the previous year’s earnings of -$22.27 million and -$1.71 per share, respectively.



Read more at Nasdaq: Gain Therapeutics Inc Full Year Loss Decreases